In 2020, healthcare distributors delivered over 51 billion personal protective equipment (PPE) supplies to providers on the frontlines of the fight against COVID-19.
Over 30 million adults have opted to take a pass on the COVID-19 vaccines, including around 3 million people over 65 years-old. They are exercising their personal choice to remain unprotected against the virus through vaccination, choosing to accept the associated risks.
Pfizer/BioNTech and Moderna have both begun clinical trials with an omicron-specific vaccine. Sounds good in theory, given that the majority of infections in the United States are with the omicron variant. However, there are numerous reason why such a product will not provide any additional benefits beyond the vaccines that are already available.
A family member became seriously ill last year. After some initial tests, a malignancy was diagnosed. Surgery was scheduled, followed by chemotherapy. Everything proceeded mostly as planned, with no medical hiccups. We are both well-educated, with backgrounds in medicine, health economics and risk analysis, which should have prepared us to maneuver the requirements of our health insurance provider and ensure that copays and pre- authorizations were handled as necessary. We were gravely mistaken.
Surprisingly, a new study has found that if you’re perceived as more popular on a mobile dating app, there is a higher chance that other users will avoid connecting with you. This is one of the major findings of a study that sought to examine the effect of a dating app user’s popularity rating on their demand on the online dating platform.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
An audio journey of how data and analytics save lives, save money and solve problems.
Cutting-edge chips, especially those designed to power emerging AI applications, tend to receive the most attention in the media and generate the most excitement. However, so-called “legacy” chips are just as important — if not more — to our daily lives.
A number of startups and cloud service providers are starting to offer tools for monitoring, evaluating, and correcting problems with generative AI in the hope of eliminating errors, hallucinations, and other systemic problems associated with this technology.
Tariffs could raise the cost of medical care and prescription drugs for people in the U.S.
New findings from a team of renowned researchers calls for transparency and rigorous oversight of the U.S. Medicare Advantage (MA) program, the United States' largest healthcare capitation program.
Dockworkers on the East and Gulf coasts could go on strike again in less than two weeks if they don’t reach a contract agreement with ports and shippers. Talks are set to resume next week, according to Bloomberg. The main sticking point between the two sides? Automation.
LONDON, Dec 30 (Reuters) - Chemicals factories founded or owned by some of Russia's wealthiest men are supplying ingredients to plants that manufacture explosives used by Moscow's military during the war in Ukraine, an analysis of railway and financial data shows.
Billionaire investor Mark Cuban's question to Representative Matt Gaetz, a Florida Republican, on energy costs took off on social media on Saturday.
Florida lawmakers have banned wind turbines off its shores and near the coast, saying the bill is meant to protect wildlife and prevent noise.